Repression of Ah receptor and induction of transforming growth factor-β genes in DEN-induced mouse liver tumors

Li Peng, Christopher N. Mayhew, Michael Schnekenburger, Erik S. Knudsen, Alvaro Puga

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the biologic and toxic effects of its xenobiotic ligands. In recent years it has become evident that in the absence of ligand the AHR promotes cell cycle progression and that its activation by high-affinity ligands results in interactions with the retinoblastoma protein (RB) that lead to perturbation of the cell cycle, G0/G1 arrest, diminished capacity for DNA replication and inhibition of cell proliferation. Hence, the AHR has diametrically opposed pro-proliferative and anti-proliferative functions that have yet to be reconciled at the molecular level. Work from our own and from other laboratories suggests that the AHR may function as a tumor suppressor gene that becomes silenced in the process of tumor formation. To develop preliminary support for a more thorough examination of this hypothesis we characterized the expression levels of various tumor suppressor genes, transforming growth factor-β (Tgfb) genes and the Ahr gene in liver tumor samples from mice with a liver-specific RB ablation and their wild-type littermates. In tumors arising in RB-positive livers, Cdkn2d and Tgfb1 were repressed and Cdkn2c, Tgfb2, Tgfb3 and Pai1 were induced, whereas in RB-negative tumors, only Cdkn2c and Tgfb3 were induced. Ahr was significantly repressed in tumors from both sets of mice, supporting the concept that Ahr silencing may be associated with cancer progression.

Original languageEnglish (US)
Pages (from-to)242-247
Number of pages6
JournalToxicology
Volume246
Issue number2-3
DOIs
StatePublished - Apr 18 2008

Fingerprint

Transforming Growth Factors
Liver
Tumors
Aryl Hydrocarbon Receptors
Retinoblastoma Protein
Genes
Ligands
Neoplasms
Tumor Suppressor Genes
G1 Phase Cell Cycle Checkpoints
Cells
Poisons
Xenobiotics
DNA Replication
Cell proliferation
Ablation
Cell Cycle
Transcription Factors
Cell Proliferation
Chemical activation

Keywords

  • Ah receptor
  • Hepatocellular carcinoma
  • TGF-β
  • Tumor suppressor genes

ASJC Scopus subject areas

  • Toxicology

Cite this

Repression of Ah receptor and induction of transforming growth factor-β genes in DEN-induced mouse liver tumors. / Peng, Li; Mayhew, Christopher N.; Schnekenburger, Michael; Knudsen, Erik S.; Puga, Alvaro.

In: Toxicology, Vol. 246, No. 2-3, 18.04.2008, p. 242-247.

Research output: Contribution to journalArticle

Peng, Li ; Mayhew, Christopher N. ; Schnekenburger, Michael ; Knudsen, Erik S. ; Puga, Alvaro. / Repression of Ah receptor and induction of transforming growth factor-β genes in DEN-induced mouse liver tumors. In: Toxicology. 2008 ; Vol. 246, No. 2-3. pp. 242-247.
@article{1f631589a1aa40f3bc47f65217a5104e,
title = "Repression of Ah receptor and induction of transforming growth factor-β genes in DEN-induced mouse liver tumors",
abstract = "The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the biologic and toxic effects of its xenobiotic ligands. In recent years it has become evident that in the absence of ligand the AHR promotes cell cycle progression and that its activation by high-affinity ligands results in interactions with the retinoblastoma protein (RB) that lead to perturbation of the cell cycle, G0/G1 arrest, diminished capacity for DNA replication and inhibition of cell proliferation. Hence, the AHR has diametrically opposed pro-proliferative and anti-proliferative functions that have yet to be reconciled at the molecular level. Work from our own and from other laboratories suggests that the AHR may function as a tumor suppressor gene that becomes silenced in the process of tumor formation. To develop preliminary support for a more thorough examination of this hypothesis we characterized the expression levels of various tumor suppressor genes, transforming growth factor-β (Tgfb) genes and the Ahr gene in liver tumor samples from mice with a liver-specific RB ablation and their wild-type littermates. In tumors arising in RB-positive livers, Cdkn2d and Tgfb1 were repressed and Cdkn2c, Tgfb2, Tgfb3 and Pai1 were induced, whereas in RB-negative tumors, only Cdkn2c and Tgfb3 were induced. Ahr was significantly repressed in tumors from both sets of mice, supporting the concept that Ahr silencing may be associated with cancer progression.",
keywords = "Ah receptor, Hepatocellular carcinoma, TGF-β, Tumor suppressor genes",
author = "Li Peng and Mayhew, {Christopher N.} and Michael Schnekenburger and Knudsen, {Erik S.} and Alvaro Puga",
year = "2008",
month = "4",
day = "18",
doi = "10.1016/j.tox.2008.01.002",
language = "English (US)",
volume = "246",
pages = "242--247",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "2-3",

}

TY - JOUR

T1 - Repression of Ah receptor and induction of transforming growth factor-β genes in DEN-induced mouse liver tumors

AU - Peng, Li

AU - Mayhew, Christopher N.

AU - Schnekenburger, Michael

AU - Knudsen, Erik S.

AU - Puga, Alvaro

PY - 2008/4/18

Y1 - 2008/4/18

N2 - The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the biologic and toxic effects of its xenobiotic ligands. In recent years it has become evident that in the absence of ligand the AHR promotes cell cycle progression and that its activation by high-affinity ligands results in interactions with the retinoblastoma protein (RB) that lead to perturbation of the cell cycle, G0/G1 arrest, diminished capacity for DNA replication and inhibition of cell proliferation. Hence, the AHR has diametrically opposed pro-proliferative and anti-proliferative functions that have yet to be reconciled at the molecular level. Work from our own and from other laboratories suggests that the AHR may function as a tumor suppressor gene that becomes silenced in the process of tumor formation. To develop preliminary support for a more thorough examination of this hypothesis we characterized the expression levels of various tumor suppressor genes, transforming growth factor-β (Tgfb) genes and the Ahr gene in liver tumor samples from mice with a liver-specific RB ablation and their wild-type littermates. In tumors arising in RB-positive livers, Cdkn2d and Tgfb1 were repressed and Cdkn2c, Tgfb2, Tgfb3 and Pai1 were induced, whereas in RB-negative tumors, only Cdkn2c and Tgfb3 were induced. Ahr was significantly repressed in tumors from both sets of mice, supporting the concept that Ahr silencing may be associated with cancer progression.

AB - The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mediates the biologic and toxic effects of its xenobiotic ligands. In recent years it has become evident that in the absence of ligand the AHR promotes cell cycle progression and that its activation by high-affinity ligands results in interactions with the retinoblastoma protein (RB) that lead to perturbation of the cell cycle, G0/G1 arrest, diminished capacity for DNA replication and inhibition of cell proliferation. Hence, the AHR has diametrically opposed pro-proliferative and anti-proliferative functions that have yet to be reconciled at the molecular level. Work from our own and from other laboratories suggests that the AHR may function as a tumor suppressor gene that becomes silenced in the process of tumor formation. To develop preliminary support for a more thorough examination of this hypothesis we characterized the expression levels of various tumor suppressor genes, transforming growth factor-β (Tgfb) genes and the Ahr gene in liver tumor samples from mice with a liver-specific RB ablation and their wild-type littermates. In tumors arising in RB-positive livers, Cdkn2d and Tgfb1 were repressed and Cdkn2c, Tgfb2, Tgfb3 and Pai1 were induced, whereas in RB-negative tumors, only Cdkn2c and Tgfb3 were induced. Ahr was significantly repressed in tumors from both sets of mice, supporting the concept that Ahr silencing may be associated with cancer progression.

KW - Ah receptor

KW - Hepatocellular carcinoma

KW - TGF-β

KW - Tumor suppressor genes

UR - http://www.scopus.com/inward/record.url?scp=40649117364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40649117364&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2008.01.002

DO - 10.1016/j.tox.2008.01.002

M3 - Article

VL - 246

SP - 242

EP - 247

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 2-3

ER -